Put Options

18 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$32.4 - $68.18 $2.62 Million - $5.52 Million
80,900 New
80,900 $5.51 Million
Q2 2022

Aug 08, 2022

SELL
$22.3 - $37.39 $22,300 - $37,390
-1,000 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$25.68 - $35.59 $15,408 - $21,354
-600 Reduced 37.5%
1,000 $35,000
Q4 2021

Feb 14, 2022

SELL
$24.9 - $40.26 $97,110 - $157,014
-3,900 Reduced 70.91%
1,600 $47,000
Q3 2021

Nov 15, 2021

SELL
$25.48 - $37.34 $983,528 - $1.44 Million
-38,600 Reduced 87.53%
5,500 $140,000
Q2 2021

Aug 16, 2021

BUY
$32.46 - $43.42 $123,348 - $164,996
3,800 Added 9.43%
44,100 $1.54 Million
Q1 2021

May 17, 2021

SELL
$38.94 - $50.85 $4.79 Million - $6.25 Million
-123,000 Reduced 75.32%
40,300 $1.64 Million
Q4 2020

Feb 16, 2021

BUY
$37.65 - $63.77 $5.82 Million - $9.87 Million
154,700 Added 1798.84%
163,300 $7.07 Million
Q3 2020

Nov 16, 2020

BUY
$52.76 - $74.49 $427,356 - $603,369
8,100 Added 1620.0%
8,600 $474,000
Q2 2020

Aug 14, 2020

SELL
$48.73 - $81.82 $311,872 - $523,647
-6,400 Reduced 92.75%
500 $32,000
Q1 2020

May 15, 2020

BUY
$41.72 - $87.2 $83,440 - $174,400
2,000 Added 40.82%
6,900 $353,000
Q4 2019

Feb 14, 2020

SELL
$45.7 - $81.86 $507,270 - $908,646
-11,100 Reduced 69.38%
4,900 $390,000
Q3 2019

Nov 14, 2019

BUY
$45.35 - $57.91 $154,190 - $196,894
3,400 Added 26.98%
16,000 $776,000
Q2 2019

Aug 14, 2019

BUY
$52.6 - $63.29 $99,940 - $120,251
1,900 Added 17.76%
12,600 $663,000
Q1 2019

May 15, 2019

BUY
$39.99 - $53.48 $379,905 - $508,059
9,500 Added 791.67%
10,700 $566,000
Q4 2018

Feb 14, 2019

BUY
$31.54 - $46.67 $37,848 - $56,004
1,200 New
1,200 $49,000
Q1 2018

May 15, 2018

SELL
$39.6 - $65.9 $194,040 - $322,910
-4,900 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$29.7 - $45.7 $145,530 - $223,930
4,900
4,900 $193,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.